Shaimaa Fayeza,
Doris Feineisa,
Virima Mudogob,
Suresh Awale*c and
Gerhard Bringmann*a
aInstitute of Organic Chemistry, University of Würzburg, Am Hubland, D-97074 Würzburg, Germany. E-mail: bringman@chemie.uni-wuerzburg.de
bFaculté des Sciences, Université de Kinshasa, B.P. 202, Kinshasa XI, Democratic Republic of the Congo
cDivision of Natural Drug Discovery, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. E-mail: suresh@inm.u-toyama.ac.jp
First published on 22nd November 2017
A striking feature of the metabolite profile of Ancistrocladus likoko (Ancistrocladaceae) is the exclusive production of 5,8′-linked naphthylisoquinoline alkaloids varying in their OMe/OH substitution patterns and in the hydrogenation degree in their isoquinoline portions. Here we present nine new compounds of this coupling type isolated from the twigs of this remarkable Central African liana. Three of them, the ancistrolikokines E (9), E2 (10), and F (11), are the first 5,8′-linked naphthyldihydroisoquinolines found in nature with R-configuration at C-3. The fourth new metabolite, ancistrolikokine G (12), is so far the only representative of the 5,8′-coupling type that belongs to the very rare group of alkaloids with a fully dehydrogenated isoquinoline portion. Moreover, five new N-methylated naphthyltetrahydroisoquinolines, named ancistrolikokines A2 (13), A3 (14), C2 (5), H (15), and H2 (16) are presented, along with six known 5,8′-linked alkaloids, previously identified in related African Ancistrocladus species, now found for the first time in A. likoko. The structural elucidation was achieved by spectroscopic analysis (HRESIMS, 1D and 2D NMR) and by chemical (oxidative degradation) and chiroptical (electronic circular dichroism) methods. The new ancistrolikokines showed moderate to good preferential cytotoxic activities towards pancreatic PANC-1 cells in nutrient-deprived medium (NDM), without causing toxicity under normal, nutrient-rich conditions, with ancistrolikokine H2 (16) being the most potent compound.
Previous phytochemical investigations on the roots and leaves of A. likoko had led to the isolation of six naphthylisoquinoline alkaloids,22,23 viz., korupensamine A (1a), the ancistrolikokines A–D (2–4 and 6), and ancistroealaine A (7), along with the biosynthetically related tetralone cis-isoshinanolone (8) (Fig. 1). All of those six alkaloids of A. likoko were based on the same coupling type, with the biaryl axis being located between C-5 and C-8′. Although this 5,8′-coupling site is quite frequently found in other Central African species like e.g., in A. ealaensis24 or A. congolensis,25,26 and, in particular in the Cameroonian liana A. korupensis, which likewise produces a whole series of 5,8′-linked naphthylisoquinolines, among them also dimers,20,27,28 no other plant produces 5,8′-coupled alkaloids exclusively.
In this paper, we report on the isolation and structural elucidation of further 5,8′-coupled naphthylisoquinoline alkaloids from the twigs of A. likoko, comprising nine new compounds (Fig. 1) and six known20,25–29 metabolites (Fig. 2); the latter had already been discovered in previous studies on related African Ancistrocladus species. Three of the new alkaloids, the ancistrolikokines E (9), E2 (10), and F (11) are the first monomeric naphthyldihydroisoquinolines with R-configuration at C-3 found in nature. Such an entity has so far been found only as part of two dimers.26,28 The fourth new alkaloid, ancistrolikokine G (12) (Fig. 1), is one of the very rare examples of fully dehydrogenated naphthylisoquinoline alkaloids that are optically active without the presence of stereogenic centers, since the only stereogenic element in 12 is the chiral biaryl axis. Prior to this work, only nine such naphthylisoquinolines have been identified in Ancistrocladus species, all of them from Asia.16,30–33 Among these compounds, ancistrolikokine G (12) is the first representative that was isolated from an African liana and that is 5,8′-coupled. Furthermore, five new N-methylated naphthyltetrahydroisoquinoline alkaloids with a 5,8′-biaryl linkage were discovered in the twigs of A. likoko, named ancistrolikokines A2 (13), A3 (14), C2 (5), H (15), and H2 (16). As part of our ongoing studies on the antiproliferative potential of naphthylisoquinoline alkaloids towards cancer cell lines,18,19,33 the new ancistrolikokines presented here, as well as related known,20,25–29 but yet not investigated 5,8′-coupled alkaloids, were tested for their activities against PANC-1 human pancreatic cancer cells under nutrient-deprived conditions.
One of these metabolites was korupensamine B (1b),27 earlier identified in A. korupensis from Cameroon. This alkaloid is the atropo-diastereomer of the co-occurring compound korupensamine A (1a)22 (Fig. 1). It was isolated from the twig extracts of A. likoko, together with two further 5,8′-coupled naphthylisoquinoline alkaloids, viz., korupensamine E (17),28 which had previously been found in A. korupensis, and ancistrocongoline A (18)25 (Fig. 2), earlier detected in the Congolese species A. congolensis. With their R-configuration at C-3 and an oxygen function at C-6, 1b, 17, and 18 belong to the subclass of mixed Ancistrocladaceae/Dioncophyllaceae-type (i.e., ‘hybrid-type’) naphthylisoquinolines. This is of special interest with respect to the chemotaxonomic relevance of naphthylisoquinoline alkaloids for the classification of the plants.
Southeast Asian and East African Ancistrocladaceae typically produce 3S-configured and 6-oxygenated compounds (i.e., ‘Ancistrocladaceae-type’ alkaloids).4,5,16–18,30–33 The only other plant family that likewise produces naphthylisoquinolines, the West African Dioncophyllaceae, exclusively contains alkaloids with R-configuration at C-3, always lacking an oxygen function at C-6 (i.e., ‘Dioncophyllaceae-type’ alkaloids).4,5,34 West African and some of the Central African Ancistrocladus plants produce both, typical Dioncophyllaceae- and Ancistrocladaceae-type alkaloids, and all possible hybrid forms thereof,4,5,11,19 while ‘Ancistrocladaceae/Dioncophyllaceae hybrid-type’ alkaloids are frequently found in Central African species together with Ancistrocladaceae-type compounds.4,5,20,22–28,35,36
Thus, in view of the structures of the alkaloids found so far in A. likoko, this liana is a typical Central African species. Besides the hybrid-type alkaloids presented above, and the two 3S-configured metabolites ancistrolikokine D (6) and ancistroealaine A (7) (Fig. 1), a further, third Ancistrocladaceae-type compound was identified, viz., ancistrobertsonine C (19)29 (Fig. 2), which had earlier been found in the Kenyan species A. robertsoniorum. The isolation of the two known hybrid-type dimers michellamine A (20)20,26 and michellamine A2 (21),26 previously detected only in A. korupensis and A. congolensis, strongly support the close chemotaxonomical relationship of A. likoko to Ancistrocladus species from West and Central Africa.
In addition, nine new 5,8′-coupled naphthylisoquinolines were discovered in the twigs of A. likoko. The molecular formula of the first new alkaloid, obtained as a dark-yellow solid, was C23H24NO4, as deduced from HRESIMS. The compound displayed NMR signals typical of a naphthyl-1,3-dimethyldihydroisoquinoline as obvious from the downfield shift of the methyl group at C-1 (δ 2.80) in the 1H NMR spectrum (Table 1) and its multiplicity (singlet), and from the low-field chemical shift of the 13C NMR signal of C-1 (δ 174.7) (Table 2). This was further corroborated from the absence of an H-1 signal, which normally appears at δ 4.60–4.80 in naphthyltetrahydroisoquinoline alkaloids.4,24,31–33 The 1H NMR spectrum showed the chemical shifts of one methoxy function (δ 4.08) and five aromatic protons, viz., three singlets and two doublets, each corresponding to one proton. Two of these protons (δ 6.67 and 6.80) were located meta to each other. This substitution pattern, with only two adjacent protons (δ 6.79 and 7.09) (Fig. 3A), hinted either at a 6′- or an 8′-position of the biaryl axis in the naphthalene portion. This assumption was supported by the ‘normal’ chemical shift of the methyl group at C-2′ (δ 2.32). The exact coupling site was established from the HMBC interaction between H-1′ and the quaternary carbon atom C-8′, thus clearly revealing that the naphthalene portion was coupled via C-8′. The attribution of H-1′ (δ 6.69) and H-3′ (δ 6.80), in turn, was assigned from the NOESY correlation sequence {H-1′ ↔ Me-2′ ↔ H-3′ ↔ OMe-4′} (Fig. 3B), and from HMBC interactions, each, from H-1′ and H-3′ to Me-2′ (Fig. 3A). In the dihydroisoquinoline portion, the axis was located at C-5, as deduced from HMBC interactions from H-7′ and H-7 to C-5, and from H-4eq to C-5 (Fig. 3A). In conclusion, the new compound was a 5,8′-coupled naphthyldihydroisoquinoline with one methoxy group at C-4′ in the naphthalene half. The three other oxygen functions had to be free hydroxy groups at C-6, C-8, and C-5′.
No. | 9 | 10 | 11 | 12 |
---|---|---|---|---|
3 | 3.75, m | 3.76, m | 3.68, m | |
4ax | 2.21, dd (10.2, 16.6) | 2.24, dd (10.2, 16.8) | 2.47, dd (11.4, 16.8) | 6.78, s |
4eq | 2.63, dd (5.4, 16.7) | 2.66, dd (5.4, 16.8) | 2.39, dd (5.8, 16.8) | |
7 | 6.53, s | 6.66, s | 6.64, s | 6.94, s |
1′ | 6.67, s | 6.64, s | 6.58, s | 6.39, s |
3′ | 6.80, s | 6.81, s | 6.68, s | 6.67, s |
6′ | 6.79, d (7.9) | 6.80, d (7.8) | 6.92, d (7.9) | 7.00, d (7.9) |
7′ | 7.09, d (7.8) | 7.10, d (7.8) | 7.07, d (7.9) | 7.10, d (7.8) |
1-CH3 | 2.80, s | 2.78, s | 2.77, s | 3.18, s |
3-CH3 | 1.18, d (6.6) | 1.19, d (6.7) | 1.24, d (6.7) | 2.38, s |
2′-CH3 | 2.32, s | 2.31, s, s | 2.26, s | 2.16, s |
8-OCH3 | 4.03, s | 4.02, s | 4.13, s | |
4′-OCH3 | 4.08, s | 4.08, s, s | ||
5′-OCH3 | 4.10, s | 4.14, s |
No. | 9 | 10 | 11 | 12 |
---|---|---|---|---|
1 | 174.7 | 175.3 | 175.5 | 157.5 |
3 | 48.7 | 49.4 | 49.3 | 142.4 |
4 | 32.5 | 32.7 | 33.4 | 118.9 |
5 | 121.7 | 122.5 | 122.3 | 114.5 |
6 | 167.1 | 167.7 | 168.0 | 165.2 |
7 | 102.3 | 99.1 | 99.1 | 101.9 |
8 | 165.0 | 165.6 | 165.7 | 163.0 |
9 | 106.8 | 108.3 | 108.7 | 114.2 |
10 | 141.0 | 142.7 | 142.5 | 143.5 |
1′ | 118.3 | 118.5 | 116.3 | 116.6 |
2′ | 137.4 | 137.9 | 139.4 | 139.5 |
3′ | 107.2 | 107.7 | 113.3 | 113.4 |
4′ | 157.9 | 158.0 | 156.1 | 156.2 |
5′ | 155.5 | 156.2 | 157.9 | 158.2 |
6′ | 110.0 | 110.3 | 104.2 | 104.6 |
7′ | 130.7 | 131.1 | 130.0 | 130.9 |
8′ | 123.0 | 122.9 | 126.0 | 125.2 |
9′ | 136.6 | 136.9 | 136.6 | 137.4 |
10′ | 114.3 | 114.8 | 114.6 | 114.9 |
1-CH3 | 24.2 | 24.8 | 24.6 | 23.6 |
3-CH3 | 17.6 | 17.9 | 18.0 | 18.7 |
2′-CH3 | 21.7 | 22.2 | 21.8 | 21.8 |
8-OCH3 | 56.6 | 56.6 | 56.7 | |
4′-OCH3 | 56.7 | 56.8 | ||
5′-OCH3 | 56.7 | 56.5 |
Fig. 3 (A) Selected 1H and 13C NMR data (δ in ppm): HMBC (single blue arrows) and NOESY (double red arrows) interactions of ancistrolikokines E (9) and E2 (10); the values of 10 that are different from those of 9 are given in { }; (B) NOESY interactions indicative of the configuration at the biaryl axis of 9 and 10 relative to the stereogenic center at C-3; (C) confirmation of the absolute axial configuration of 9 by comparison of its ECD spectrum with that of the known18 related 5,8′-coupled alkaloid 6-O-demethylancistectorine D (22). |
The absolute configuration at C-3 in the dihydroisoquinoline portion was determined by ruthenium-mediated oxidative degradation as described earlier,37 by stereochemical analysis of the resulting amino acids by gas chromatography with mass-selective detection (GC-MSD) after derivatization with the R-enantiomer of Mosher's acid chloride. The formation of R-3-aminobutyric acid unequivocally established the alkaloid to be R-configured at C-3.
The relative and, thus, absolute configuration at the biaryl axis was attributed to be P, by NOESY interactions between H-4ax and H-1′ on the one hand, and between H-4eq and H-7′ on the other (Fig. 3B). The assignment of the absolute axial configuration as P was confirmed by the fact that the ECD spectrum of the new metabolite was virtually opposite to that of the structurally closely related and likewise 5,8′-coupled, but M-configured 6-O-demethylancistectorine D (22)18 (Fig. 3C).
Thus, the new alkaloid had the full absolute stereostructure 9 as shown in Fig. 1. It was henceforth named ancistrolikokine E, in continuation of the series of alkaloids previously isolated from A. likoko.22,23 It is the first 5,8′-coupled naphthyldihydroisoquinoline found in nature with R-configuration at C-3.
The second new alkaloid, isolated from the twig extracts of A. likoko, showed 1H and 13C NMR data again suggesting the presence of a naphthyldihydroisoquinoline alkaloid belonging to the 5,8′-coupling type. It strongly resembled the constitution of the above-presented ancistrolikokine E (9), yet with a higher degree of O-methylation. According to HRESIMS, the new compound corresponded to a molecular formula of C24H26NO4, and the NOESY correlation sequence {Me-1 ↔ OMe-8 ↔ H-7} (Fig. 3A) revealed the new metabolite to be equipped with a methoxy group (δ 4.03) at C-8 in the dihydroisoquinoline portion.
By the above-mentioned methods – the oxidative degradation, specific NOESY interactions across the biaryl axis (see Fig. 3B), and ECD spectroscopy (see the ESI†) – the new alkaloid was established to be R-configured at C-3 and P-configured at the axis, similar to ancistrolikokine E (9). The new metabolite had the complete stereostructure 10 (Fig. 1). It is the 8-O-methyl analog of ancistrolikokine E (9), and was thus named ancistrolikokine E2.
The molecular formula of the third new alkaloid, as established from the HRESIMS and 13C NMR spectroscopic data (Table 2), was C24H26NO4, and, thus, the same as that of ancistrolikokine E2 (10). 1H NMR investigations (Table 1) again indicated the presence of a 5,8′-coupled naphthyl-1,3-dimethyldihydroisoquinoline with two normally shifted methoxy groups (δ 4.02 and 4.10), the only difference between 10 and the new metabolite being the OH/OMe pattern in their naphthalene parts. In 10 the methoxy group was located at C-4′, while the new metabolite was equipped with a methoxy function at C-5′ as assigned by cross-peaks in the NOESY spectrum in the series {OMe-5′ ↔ H-6′ ↔ H-7′}. This was further confirmed by an NOE interaction between H-3′ and Me-2′, which, in turn, showed an NOE correlation to H-1′ (Fig. 4A).
Fig. 4 (A) NOESY interactions indicative of the configuration at the biaryl axis of ancistrolikokine F (11) relative to the stereogenic center; (B) confirmation of the absolute axial configuration of 11 by comparison of its ECD spectrum with that of the known18 related 5,8′-coupled alkaloid 6-O-demethylancistectorine D (22), for its structure, see Fig. 3. |
The formation of R-3-aminobutyric acid in the degradation procedure proved the new alkaloid to be R-configured at C-3. Long-range NOESY interactions between H-4ax and H-7′ and between H-4eq and H-1′ permitted assignment of the stereo array at the axis to be M as shown in Fig. 4A. This was in agreement with the ECD spectrum of the compound, which was nearly identical to that of the likewise M-configured 6-O-demethylancistectorine D (22)18 (Fig. 4B). Hence, the new alkaloid possessed the stereostructure 11. It was named ancistrolikokine F.
The fourth new alkaloid possessed a molecular formula of C24H24NO4, as deduced from HRESIMS. The 1H and 13C NMR spectroscopic data (Table 1) and specific HMBC and ROESY interactions (see ESI†) of the new metabolite corresponded to the presence of a 5,8′-coupled naphthylisoquinoline alkaloid with an OH/OMe pattern identical to that of ancistrolikokine F (11). The 1H NMR spectrum of the new metabolite implied the presence of a fully dehydrogenated isoquinoline portion. This was obvious from the lack of resonances for protons at C-1 and C-3 and the appearance of an additional aromatic singlet at δ 6.78, instead of the signals of the two diastereotopic geminal protons at C-4 usually observed for naphthyltetra- or naphthyldihydroisoquinoline alkaloids.31–33 This finding was further supported by the significant downfield shifts of the signals of the two methyl groups at C-1 (δ 3.18) and C-3 (δ 2.38) in the 1H NMR spectrum (Table 1) and of the 13C NMR resonances of C-1, C-3, and C-4 (δ 157.5, 142.4, and 118.9, respectively) (Table 2).
Owing to the lack of stereogenic centers in the isoquinoline moiety, the biaryl axis was the only stereogenic element of the new alkaloid. Its absolute axial configuration (Fig. 5) was easily determined to be M due to its opposite ECD spectrum compared to that of the 5,1′-coupled ancistrocladeine (23),38 a known, likewise fully dehydrogenated, but P-configured alkaloid previously obtained by semi-synthesis from ancistrocladine.38,39 The new alkaloid thus possesses the structure 12. It was named ancistrolikokine G.
Fig. 5 Assignment of the absolute axial configuration of ancistrolikokine G (12), by comparison of its ECD spectrum with that of the known P-configured ancistrocladeine (23).38,39 |
HPLC analysis of this new metabolite of A. likoko on a chiral phase (Chiralcel® OD-H) resulted in only one peak, and the ECD spectra recorded at different positions of the peak (e.g. left or right slope) were all identical, suggesting that this fully dehydrogenated naphthylisoquinoline alkaloid 12 is apparently produced by A. likoko in an enantiomerically pure form.
Non-hydrogenated, fully aromatic naphthylisoquinoline alkaloids have as yet been found quite rarely in nature. While some of them were reported to occur in the plants in a completely racemic form,4,32,40–43 other representatives of this subtype were found to be optically active.16,30–33 Ancistrolikokine G (12) is the first naturally occurring such merely axially chiral alkaloid possessing a 5,8′-biaryl linkage – a remarkable finding with respect to the fact that the metabolite pattern of most of the Central African Ancistrocladus plants20–28 is dominated by 5,8′-coupled – yet always hydrogenated – naphthylisoquinoline alkaloids.
Resolution of one of the more nonpolar CC fractions by preparative RP-HPLC yielded five further pure new naphthylisoquinoline alkaloids. The 1H (Table 3) and 13C NMR (Table 4) data and specific NOE correlations (Fig. 6A) of these compounds hinted at the presence of naphthyltetrahydroisoquinolines, again belonging to the 5,8′-coupling type. The NMR data clearly revealed a great structural similarity of these metabolites, which only differed by their OH/OMe substitution patterns and the relative configuration in their tetrahydroisoquinoline portions.
No. | 13 | 14 | 5 | 15 | 16 |
---|---|---|---|---|---|
1 | 4.73, q | 4.73, q | 4.76, q | 4.65, q | 4.68, q |
3 | 3.96, m | 3.98, m | 3.95, m | 3.21, m | 3.17, m |
4ax | 2.03, dd (11.8, 18.5) | 2.04, dd (11.7, 18.6) | 2.04, dd (11.8, 18.3) | 2.56, dd (11.4, 17.3) | 2.59, dd (11.4, 17.3) |
4eq | 2.64, dd (5.0, 18.6) | 2.63, dd (4.9, 18.6) | 2.25, dd (5.1, 18.3) | 2.22, dd (2.9, 17.3) | 2.24, dd (3.0, 17.3) |
7 | 6.60, s | 6.61, s | 6.78, s | 6.55, s | 6.75, s |
1′ | 6.61, s | 6.60, s | 6.51, s | 6.61, s | 6.58, s |
3′ | 6.79, s | 6.68, s | 6.64, s | 6.78, s | 6.78, s |
6′ | 6.81, d (7.8) | 6.94, d (7.9) | 6.90, d (7.9) | 6.76, d (7.8) | 6.76, d (7.8) |
7′ | 7.11, d (7.8) | 7.16, d (7.9) | 7.06, d (7.9) | 7.02, d (7.8) | 7.03, d (7.8) |
1-CH3 | 1.67, d (6.7) | 1.68, d (6.7) | 1.70, d (6.7), s | 1.77, d (6.6) | 1.72, d (6.6) |
3-CH3 | 1.19, d (6.5) | 1.19, d (6.5) | 1.23, d (6.5) | 1.19, d (6.5) | 1.27, d (6.5) |
N-CH3 | 2.70, s | 2.70, s | 2.75, s | 3.03, s | 3.03, s |
2′-CH3 | 2.30, s | 2.28, s, s | 2.23, s | 2.29, s | 2.29, s |
6-OCH3 | 4.00, s | 3.57, s | 3.65, s | ||
8-OCH3 | 3.90, s | 3.92, s | 3.66, s | 3.99, s | |
4′-OCH3 | 4.08, s | 3.92, s, s | 4.08, s | 4.08, s | |
5′-OCH3 | 3.95, s | 4.10, s |
No. | 13 | 14 | 5 | 15 | 16 |
---|---|---|---|---|---|
1 | 59.6 | 59.6 | 59.6 | 62.4 | 62.2 |
3 | 50.5 | 50.6 | 50.5 | 60.4 | 60.5 |
4 | 29.2 | 29.1 | 29.6 | 34.1 | 34.3 |
5 | 120.0 | 120.4 | 121.8 | 120.7 | 121.8 |
6 | 157.5 | 157.4 | 158.5 | 159.7 | 160.1 |
7 | 99.0 | 98.9 | 95.5 | 98.8 | 95.9 |
8 | 158.2 | 158.2 | 160.0 | 155.7 | 157.9 |
9 | 111.8 | 111.9 | 112.9 | 113.5 | 115.2 |
10 | 132.2 | 132.3 | 132.1 | 134.3 | 134.6 |
1′ | 118.4 | 117.5 | 116.3 | 119.0 | 119.0 |
2′ | 137.8 | 138.1 | 139.0 | 137.2 | 137.1 |
3′ | 107.4 | 109.9 | 113.0 | 107.5 | 107.6 |
4′ | 158.1 | 158.9 | 156.0 | 157.9 | 158.0 |
5′ | 155.9 | 158.4 | 157.2 | 155.7 | 155.8 |
6′ | 110.5 | 106.7 | 104.4 | 110.1 | 110.3 |
7′ | 131.3 | 130.2 | 129.4 | 131.5 | 131.6 |
8′ | 124.2 | 126.0 | 127.7 | 124.7 | 124.8 |
9′ | 137.1 | 137.6 | 136.8 | 136.8 | 137.0 |
10′ | 115.0 | 117.6 | 114.7 | 114.6 | 114.8 |
1-CH3 | 19.1 | 19.0 | 19.2 | 19.3 | 19.8 |
3-CH3 | 16.5 | 16.2 | 16.7 | 17.9 | 18.0 |
N-CH3 | 33.8 | 33.9 | 34.1 | 41.2 | 41.6 |
2′-CH3 | 22.1 | 22.0 | 21.8 | 22.0 | 22.3 |
6-OCH3 | 56.3 | 55.8 | 56.4 | ||
8-OCH3 | 56.1 | 56.1 | 56.2 | 56.4 | |
4′-OCH3 | 56.7 | 56.9 | 56.7 | 57.0 | |
5′-OCH3 | 56.7 | 56.6 |
Fig. 6 (A) Selected 1H and 13C NMR data (δ in ppm), HMBC (single blue arrows) and NOE (double red arrows) interactions of ancistrolikokine A2 (13); (B) NOESY correlations evidencing the relative configuration of 13 (top), ancistrolikokine C2 (5) (middle), and ancistrolikokine H (15) (bottom) at the biaryl axis and at the stereogenic centers C-1 and C-3 in the isoquinoline part; (C) assignment of the absolute axial configuration of 13 (left) and 5 (right) by comparison of their CD spectra with that of the known22 P-configured ancistrolikokine C (4). |
The first compound within this series of new metabolites had a molecular formula of C25H29NO4, as evidenced by HRESIMS. It was found to possess two methoxy groups (δ 3.90 and 4.08), which were attributed to be located at C-4′ and C-8, three C-methyl groups (δ 1.19, 1.67, and 2.30), and a three-proton singlet resonating at δ 2.70, typical of an N-CH3 group. From a ROESY correlation between H-3 and CH3-1 (Fig. 6B), a relative trans-configuration of the two stereocenters at C-1 and C-3 was established. The absolute configurations determined by ruthenium-mediated oxidative degradation,37 were found to be R, both for C-1 and C-3. On the basis of the known configuration at the stereocenters, the relative and thus also the absolute configuration at the biaryl axis was deduced from ROESY interactions between Hax-4 and H-1′, and between Heq-4 and H-7′, showing the axis to be P-configured (Fig. 6B, top). This attribution was further confirmed by the fact that the ECD spectrum of the isolated compound was opposite to that of the M-configured, and likewise 5,8′-coupled ancistrolikokine C (4)22 (Fig. 6C, left). Thus, the new naphthyltetrahydroisoquinoline possessed the stereostructure 13 and was hence the 6-O-demethyl-8-O-methyl analog of ancistrolikokine A (2), which is a main alkaloid of A. likoko.22 It was therefore named ancistrolikokine A2. Alternately, the as yet unknown metabolite 13 might be addressed as the 8-O-methyl analog of the co-occurring ancistrocongoline A (18).25
The second new compound within this series of five N-methylated naphthylisoquinoline alkaloids isolated from the twig extract of A. likoko corresponded to a molecular formula of C26H31NO4, according to HRESIMS. The most significant difference within the NMR data compared to those of 13 (Table 3) was an upfield-shifted signal of the methoxy group at C-5' (δ 3.95) monitored for the new compound. Like in 13, the relative configuration at C-1 versus C-3 was deduced to be trans from specific HMBC and NOE interactions, and again the absolute configurations were assigned to be 1R,3R by ruthenium-mediated oxidative degradation.37 ECD spectroscopy established the compound to be P-configured at the biaryl axis (see ESI†). The alkaloid thus had the stereostructure 14 as presented in Fig. 1. It was the new 5′-O-methyl analog of 13, and was thus named ancistrolikokine A3 (14). It could likewise be addressed as the 5′,8-O,O-dimethyl analog of the co-occurring ancistrocongoline A (18).25
HRESIMS analysis of the third of these five N-methylated naphthylisoquinoline alkaloids gave the same molecular formula of C26H31NO4 as determined for ancistrolikokine A3 (14). NMR measurements revealed that this new metabolite, different from 14, possessed a free hydroxy function at C-4′ and a methoxy group at C-6 (Table 3). Similar to 13 and 14, the two methyl groups at C-1 and C-3 were trans to each other, and again, both C-1 and C-3 were R-configured, as obvious from the results of the oxidative degradation.37 Long-range NOE interactions between Hax-4 and H-7′, and between Heq-4 and H-1′, evidenced the biaryl axis to be M-configured (Fig. 6B, center). This was confirmed by the nearly identical ECD spectrum of the new alkaloid compared to that of the likewise M-configured ancistrolikokine C (4)22 (Fig. 6C, right). The new compound thus had the stereostructure 5 as displayed in Fig. 1. It is the 6-O-methyl analog of the co-occurring ancistrolikokine C (4)22 and was henceforth named ancistrolikokine C2.
The molecular formula of the fourth new N-methylated alkaloid was C25H29NO4, as established by HRESIMS. The NMR data were typical of a 5,8′-coupled naphthyltetrahydroisoquinoline equipped with two methoxy groups at C-4′ and C-6 (δ 4.08 and 3.57), leaving the other two oxygenated carbon atoms, C-5′ and C-8, to bear free hydroxy functions. The constitution and the spectroscopic data of this new natural product, except for the methoxy group at C-6, were in good agreement with those of the known27 alkaloid korupensamine D from A. korupensis. From an NOE correlation between H-1 (δ 4.65) and H-3 (δ 3.21) the relative configuration at C-1 versus C-3 was deduced to be cis (Fig. 6B, bottom). The formation of S-N-methyl-3-aminobutyric acid by oxidative degradation37 proved the new metabolite to be S-configured at C-3 and, given the relative cis-configuration at C-1 and C-3 in the tetrahydroisoquinoline moiety, indicated C-1 to be R-configured. NOESY interactions between H-4eq and H-1′, and between H-4ax and H-7′, in conjunction with the S-configuration at C-3, unequivocally confirmed the biaryl axis to be P-configured. This alkaloid thus had the full absolute stereostructure 15 as shown in Fig. 1 and was, hence, new. In continuation of the series of new alkaloids of the 5,8′-coupling type discovered in A. likoko, it was named ancistrolikokine H. This compound can likewise be addressed as 6-O-methylkorupensamine D.
The last isolated new alkaloid was found to possess a molecular formula of C26H31NO4, showing 14 additional mass units compared to 15 (corresponding to an extra CH2 portion). Its 1H and 13C NMR spectra were very similar to those of 15, the only structural difference being the presence of a further O-methyl group in the isoquinoline moiety of the new metabolite. By NOESY measurements, this methoxy group was established to be located at C-8. By oxidative degradation and specific NOE interactions, the isoquinoline was, similar to 15, again found to be 1R,3S-configured. Like for 15, NOE interactions revealed the axis to be P-configured, corroborated by ECD spectroscopy (see ESI†). The results showed the compound to possess structure 16 as presented in Fig. 1, and, thus, to be the likewise new 8-O-methyl analog of 15; it was named ancistrolikokine H2. The new metabolite can also be addressed as the 5′-O-demethyl derivative of the co-occurring known29 alkaloid ancistrobertsonine C (19) (Fig. 2).
Despite great research efforts to better understand the pancreatic tumor microenvironment, the prognosis of this severe malignant cancer disease still remains dismal. A particular problem is that treatment suffers from the rapid development of multidrug-resistance of the tumor cells towards conventional chemotherapeutic agents,46,47 and from the fact that the pancreatic cancer cells show a high tolerance against extreme nutrition starvation, enabling them to proliferate aggressively under extremely hypovascular (austerity) and hypoxic conditions.45,48 Accordingly, novel treatment strategies against pancreatic cancer are urgently needed.
The antiausterity approach44,45 aims at the identification and development of new targeted agents44,49–51 with preferential cytotoxicity to pancreatic tumor cells under nutrient-deficient conditions. The preferential cytotoxicites are represented as PC50 values, i.e., the concentration at which 50% of the pancreatic cancer cells were killed in NDM without exhibiting toxicity at normal nutrient-rich medium.
All of the naphthylisoquinoline alkaloids tested displayed moderate to strong preferential cytotoxicities against the PANC-1 cell line, with micromolar PC50 values ranging from 4.89 to 110.1 μM (Table 5). Ancistrolikokine H2 (16) exerted the most potent effects in NDM, with a PC50 value of 4.89 μM (Fig. 7). The test results showed that the OMe/OH substitution patterns of the isoquinoline portion seem to play a crucial role for the cytotoxic potential within this series of 5,8′-coupled naphthylisoquinoline alkaloids. Ancistrolikokine E (9), with two hydroxy functions at C-6 and C-8, showed only moderate preferential cytotoxicity (PC50, 61.5 μM), whereas ancistrolikokine E2 (10) with its mixed 6-OH/8-OMe-substituted dihydroisoquinoline subunit, displayed a very good activity against the PANC-1 cells (PC50, 18.1 μM). This tendency was supported, on the one hand, by the likewise strong preferential cytotoxicity of the ancistrolikokines C2 (5) and H2 (16) (PC50, 10.1 and 4.89 μM), equipped with two O-methyl groups at C-6 and C-8, and, on the other hand, by the only moderate to weak activities of the korupensamines A (1a) and B (1b) (PC50, 110.1 and 94.9 μM), possessing a 6,8-dihydroxy substituted tetrahydroisoquinoline half. By contrast, a distinct influence of the oxygenation pattern of the naphthalene part at C-4′ and C-5′ (OMe/OH vs. OH/OMe) was not found, as obvious from nearly similar preferential cytotoxicities of 5 and 16 (PC50, 10.1 and 4.89 μM) and 10 and 11 (PC50, 18.1 and 20.8 μM).
Compound | PC50a (in μM) | Compound | PC50a (in μM) |
---|---|---|---|
a Concentration at which 50% of the cells were killed preferentially in NDM.b Used as a reference compound. | |||
1a | 110.1 | 14 | 40.2 |
1b | 94.9 | 15 | 26.8 |
3 | 9.74 | 16 | 4.89 |
4 | 7.11 | 17 | 7.72 |
5 | 10.1 | 18 | 20.0 |
9 | 61.5 | 19 | 28.3 |
10 | 18.1 | 20 | 41.5 |
11 | 20.8 | 8 | 41.7 |
13 | 28.9 | arctigeninb | 0.475 |
Furthermore, the test results indicate that the degree of dehydrogenation in the isoquinoline portion had no significant impact on the biological activity of this series of 5,8′-linked naphthylisoquinoline alkaloids, since among the most active compounds (PC50 < 30 μM), there were naphthyldihydroisoquinolines like 10 and 11, but also naphthyltetrahydroisoquinolines like 3–5 and 17. N-Methylation of the alkaloids did not seem to be an important structural element either, as suggested by the nearly identical PC50 values observed for korupensamine E (17) (PC50, 7.72 μM) and its N-methylated analog ancistrolikokine C (4) (PC50, 7.11 μM).
Fraction 5 (F5, 80 mg) was resolved on a silica gel column with n-hexane/CH2Cl2 and CH2Cl2/MeOH gradients and further purified by preparative HPLC, applying a linear gradient (0 min 10% B, 16 min 55% B), finally providing cis-isoshinanolone (8) (1.0 mg) (retention time 15.1 min).
From fraction 9 (F9, 500 mg), six alkaloids were isolated by isocratic HPLC with 26% aqueous MeCN acidified with 0.05% trifluoroacetic acid, viz., ancistrolikokine A3 (14) (2 mg) (retention time 14.3 min), ancistrolikokine A2 (13) (4.0 mg) (retention time 18.0 min), ancistrolikokine H (15) (3.0 mg) (retention time 20.2 min), ancistrobertsonine C (19) (2 mg) (retention time 28.5 min), ancistrolikokine H2 (16) (5.0 mg) (retention time 39.8 min), and ancistrolikokine C2 (5) (2.0 mg) (retention time 48.0 min).
Fraction 10 (F10, 1.07 g) was repeatedly subjected to CC on silica gel with n-hexane/CH2Cl2 and CH2Cl2/MeOH (90:10 to 55:45) as the eluent yielding 24 subfractions (F101–F1024), which were further resolved by preparative HPLC. From F1017, pure ancistrolikokine B (3) (3.0 mg) (retention time 11.7 min) and korupensamine E (17) (4.0 mg) (retention time 12.2 min) were obtained, by applying the following gradient: 0 min 25% B, 10 min 45% B, 19 min 49% B, 19 min 49% B, 25 min 55% B, 26 min 55% B. Purification of F1021 under gradient conditions (0 min 10% B, 11 min 40% B, 27 min 45% B) furnished ancistrolikokine C (4) (5.0 mg) (retention time 16.2 min), while resolution of F1016 using a modified solvent system (0 min 2% B, 5 min 10% B, 8 min 20% B, 12 min 35% B, 14 min 36.4% B, 24 min 37.5% B, 35 min 65%) yielded ancistrolikokine G (12) (0.6 mg) (retention time 21.1 min).
Fraction 12 (F12, 300 mg) was further purified by preparative HPLC, using the following gradient: 0 min 20% B, 20 min 37% B, 24 min 60% B, finally giving rise to ancistrocongoline A (18) (10.0 mg) (retention time 17.9 min), ancistrolikokine E2 (10) (6.0 mg) (retention time 20.0 min), and ancistrolikokine F (11) (10.0 mg) (retention time 20.2 min).
From fraction 13 (F13, 1.6 g), korupensamine A (1a) (23 mg) (retention time 18.0 min) and korupensamine B (1b) (16 mg) (retention time 19.0) were obtained by HPLC under gradient conditions (0 min 10% B, 11 min 25% B, 27 min 55% B). Using a linear gradient (0 min 25% B, 12 min 30% B, 24 min 55% B), preparative HPLC of fraction 15 (F15, 170 mg) provided pure ancistrolikokine E (9) (3.0 mg) (retention time 20.8 min).
The most polar fraction 17 (F17, 1.1 g) was directly submitted to HPLC, using a linear gradient (0 min 20% B, 14 min 37% B, 16 min 47% B, 23 min 100% B) to give michellamine A (20) (2.0 mg) (retention time 12.0 min) and michellamine A2 (21) (0.5 mg) (retention time 12.5 min).
Cell viability (%) = [Abs(test sample) − Abs(blank)/Abs(control) − Abs(blank)] × 100% |
Furthermore, this plant has become a promising source of potent bioactive compounds, with interesting preferential cytotoxicities against PANC-1 human cancer cells. The fact that pancreatic cancer is an aggressive malignant disease with a low survival rate, rapidly developing resistance to systemic therapies with conventional drugs, urgently demands the development of new anti-cancer agents. The promising activities of some of the ancistrolikokines warrant further investigations on the anticancer potential of naphthylisoquinoline alkaloids in general. More-in-depth studies towards this goal are presently in progress.
Footnote |
† Electronic supplementary information (ESI) available: Spectroscopic data include NMR (1H, 13C, 1H,1H-COSY, HSQC, HMBC, NOESY, and ROESY), HRESIMS, IR, and ECD spectra of compounds 5 and 9–16. See DOI: 10.1039/c7ra11200a |
This journal is © The Royal Society of Chemistry 2017 |